Stay updated with breaking news from 15117b10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Celldex Therapeutics, Inc. (NASDAQ:CLDX – Get Free Report) has received a consensus rating of “Moderate Buy” from the five brokerages that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average 1-year price target among […]
Celldex Therapeutics, Inc. (NASDAQ:CLDX – Get Free Report) shares were up 2.7% on Wednesday . The company traded as high as $39.81 and last traded at $39.66. Approximately 202,977 shares traded hands during trading, a decline of 77% from the average daily volume of 896,324 shares. The stock had previously closed at $38.60. Wall Street […]
Shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX – Get Free Report) were up 2.7% during mid-day trading on Wednesday . The company traded as high as $39.81 and last traded at $39.66. 202,977 shares were traded during mid-day trading, a decline of 77% from the average session volume of 896,324 shares. The stock had previously closed […]
Profund Advisors LLC cut its position in shares of Celldex Therapeutics, Inc. (NASDAQ:CLDX – Free Report) by 25.1% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 28,039 shares of the biopharmaceutical company’s stock after selling 9,382 shares during the period. Profund […]
Celldex Therapeutics, Inc. (NASDAQ:CLDX – Get Free Report) has been given a consensus rating of “Moderate Buy” by the five brokerages that are covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month target […]